Close Menu
The Cannabis Journal

    Subscribe to Updates

    Get the latest creative news from The Cannabis Journal

    What's Hot

    Trump’s Truth Social Post Sparks Buzz — Enthusiasts See New Signal

    September 29, 2025

    MMJ’s Cannabis Softgel Approach Offers a New Path in Huntington’s Disease — Scalable Alternative to Gene Therapy?

    September 26, 2025

    A New Alliance: Nvidia Invests in Intel Amidst Geopolitical Shifts

    September 23, 2025
    X (Twitter) Instagram
    The Cannabis JournalThe Cannabis Journal Monday, October 6
    Trending
    • Trump’s Truth Social Post Sparks Buzz — Enthusiasts See New Signal
    • MMJ’s Cannabis Softgel Approach Offers a New Path in Huntington’s Disease — Scalable Alternative to Gene Therapy?
    • A New Alliance: Nvidia Invests in Intel Amidst Geopolitical Shifts
    • Tilray and Sundial Growers Navigate Shifting Cannabis Landscape Amid Regulatory Optimism
    • The Value of REITs in a Dividend Portfolio: Spotlight on AGNC, Realty Income, and VICI
    • High Tide Poised for Strong Q3 Results After August Guidance — What to Watch
    • Klarna’s NYSE Debut: Europe’s BNPL Giant Eyes U.S. Expansion Amid Investor Buzz
    • Rescheduling Hope Ignites Buzz in Cannabis Industry — But Is the Optimism Warranted?
    The Cannabis JournalThe Cannabis Journal
    • Home
    • Cannabis News
    • Stocks
    • High Tide Inc.
    • About Us
    The Cannabis Journal
    Home»Cannabis News»Tilray Medical Strengthens Position in Germany
    Cannabis News

    Tilray Medical Strengthens Position in Germany

    The Cannabis JournalBy The Cannabis JournalAugust 29, 2025Updated:August 29, 2025No Comments4 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    Share
    Facebook Twitter LinkedIn Pinterest Email



    Highlights;

    Tilray Medical’s Expansion into the German Medical Cannabis Market

    • Company Overview: Tilray Medical, part of Tilray Brands Inc., is a global leader in medicinal cannabis, focusing on improving healthcare through informed decisions between patients and healthcare providers.

    • New Product Launch: Three new EU-GMP certified medical cannabis strains are introduced under the Good Supply brand:

      • Good Supply Cannabisblüten THC 22 IIM: Available early September.
      • Good Supply Cannabisblüten THC 25 MMK: Launching mid-September (19th).
      • Good Supply Cannabisblüten THC 18 LLD: Available late September or early October.
    • Product Sizes: Each strain is offered in 15g jars for patients and 500g packs for pharmacies, catering to diverse needs.

    • Brand and Quality: The Good Supply portfolio, renowned in Canada for quality, is now tailored for Germany, emphasizing consistent quality and accessible formats.

    • Distribution and Logistics: Tilray supplies these products to German pharmacies, supported by a robust logistics network ensuring reliable and high-quality supply.

    • Market Strategy: The staggered release and product range aim to enhance market presence and cater to broader patient needs, leveraging Tilray’s international platform for potential expansion.

    • Regulatory Compliance and Reputation: EU-GMP certification assures safety and quality, reinforcing Tilray’s reputation as a trusted leader in medical cannabis.

    • Conclusion: This expansion underscores Tilray’s commitment to quality, reliability, and patient care, positioning them for growth in Europe and beyond.


    FOR IMMEDIATE RELEASE

    LONDON and NEUMÜNSTER, Germany, Aug. 28, 2025 – Tilray Medical, a division of Tilray Brands Inc. and a global leader in medical cannabis, today announced the launch of three new EU-GMP certified medical cannabis strains in Germany under the Good Supply brand. These new offerings—Good Supply Cannabisblüten THC 22 IIM, Good Supply Cannabisblüten THC 25 MMK, and Good Supply Cannabisblüten THC 18 LLD—are designed to meet the diverse needs of patients and pharmacies in Germany. Each strain will be available in 15-gram jars for patients and 500-gram packs for pharmacies, ensuring accessibility and convenience under Germany’s medical cannabis framework.

    Tilray Medical is committed to empowering patients and healthcare practitioners by providing high-quality, EU-GMP certified products that enable informed, individualized health decisions. These new strains expand Tilray’s portfolio in Germany, building on the success of the Good Supply brand, which is renowned for its consistent quality and accessible formats.

    “Our unwavering commitment to leadership in the global medical cannabis industry is rooted in our dedication to patient care and advancing healthcare standards worldwide,” said Rajnish Ohri, Managing Director, International, Tilray Brands. “By introducing these new Good Supply strains, we are expanding access to premium, EU-GMP certified options for physicians and patients in Germany while reaffirming our role as a trusted partner in medical cannabis. Our robust international platform and strong distribution network enable us to deliver consistent quality and reliable supply, ensuring patients have access to safe and effective medical choices.”

    The Good Supply Cannabisblüten THC 22 IIM strain will be available starting September 1, followed by Good Supply Cannabisblüten THC 25 MMK on September 19. Good Supply Cannabisblüten THC 18 LLD is expected to launch by the end of September or early October.

    Tilray Medical has established itself as a leader in supplying EU-GMP certified medical cannabis to pharmacies across Germany, where products are dispensed by prescription. The company’s German logistics and distribution network ensures reliable access to these new strains, further solidifying Tilray’s position as a trusted partner in the European medical cannabis market.

    For more information, visit Tilray Medical’s website or contact your local pharmacy for availability.

    About Tilray Medical
    Tilray Medical is a leading global supplier of EU-GMP certified medical cannabis products. As part of Tilray Brands Inc., a global cannabis leader, Tilray Medical is dedicated to advancing patient care and healthcare standards worldwide. With a strong focus on quality, innovation, and patient well-being, Tilray Medical continues to expand its portfolio of premium medical cannabis products, ensuring safe and reliable access for patients in need.

    Contact Information
    Tilray Medical
    Email: mailto:info@tilraymedical.com
    Phone: +49 (0) 4321 12345
    Website: www.tilraymedical.com


    This rewritten version removes the HTML formatting and focuses on the core content, presenting it in a clean, professional format suitable for a press release.



    Source: https://www.cannabisbusinesstimes.com/business-issues-benchmarks/medical-cannabis-access-and-pricing/news/15754104/tilray-medical-expands-presence-in-germany

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticlePlanet Based Foods Clears CAD $800K Debt via Share Issuance
    Next Article Ein Gespräch mit Steffen Seibert – POLITICO
    The Cannabis Journal
    • Website

    Related Posts

    Cannabis News

    Trump’s Truth Social Post Sparks Buzz — Enthusiasts See New Signal

    September 29, 2025
    Cannabis News

    MMJ’s Cannabis Softgel Approach Offers a New Path in Huntington’s Disease — Scalable Alternative to Gene Therapy?

    September 26, 2025
    Cannabis News

    Tilray and Sundial Growers Navigate Shifting Cannabis Landscape Amid Regulatory Optimism

    September 17, 2025
    Add A Comment
    Leave A Reply Cancel Reply

    Latest

    Trump’s Truth Social Post Sparks Buzz — Enthusiasts See New Signal

    September 29, 20255 Views

    MMJ’s Cannabis Softgel Approach Offers a New Path in Huntington’s Disease — Scalable Alternative to Gene Therapy?

    September 26, 20252 Views

    A New Alliance: Nvidia Invests in Intel Amidst Geopolitical Shifts

    September 23, 20251 Views

    Tilray and Sundial Growers Navigate Shifting Cannabis Landscape Amid Regulatory Optimism

    September 17, 20255 Views
    Stay In Touch
    • Twitter
    • Instagram

    Subscribe to Updates

    Get the latest tech news from The Cannabis Journal.

    Most Popular

    High Tide Surges Ahead as Integrity and Scale Define Industry Leadership

    September 4, 20259 Views

    Tilray Stock: Stunning 5x Growth Potential Revealed

    August 26, 20258 Views

    German Retail Acquisition Pending for High Tide – New Cannabis Ventures

    August 21, 20258 Views
    Our Picks

    Trump’s Truth Social Post Sparks Buzz — Enthusiasts See New Signal

    September 29, 2025

    MMJ’s Cannabis Softgel Approach Offers a New Path in Huntington’s Disease — Scalable Alternative to Gene Therapy?

    September 26, 2025

    A New Alliance: Nvidia Invests in Intel Amidst Geopolitical Shifts

    September 23, 2025

    Subscribe to Updates

    Get the latest creative news from The Cannabis Journal

    Facebook X (Twitter) Instagram Pinterest
    • About Us
    • Contact Us
    • Privacy Policy
    • Terms & Conditions
    • Disclaimer
    © 2025 ThemeSphere. Designed by ThemeSphere.

    Type above and press Enter to search. Press Esc to cancel.

    Ad Blocker Enabled!
    Ad Blocker Enabled!
    To make it possible to run this website, we would love to show you some ads! Please <3 Thanks - The Cannabis Journal